SOPHiA GENETICS S.A.
SOPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $208,695 | $221,924 | $204,663 |
| - Cash | $81,610 | $94,822 | $68,528 | $80,226 |
| + Debt | $60,764 | $63,813 | $30,130 | $30,030 |
| Enterprise Value | – | $177,686 | $183,526 | $154,467 |
| Revenue | $19,462 | $18,323 | $17,779 | $17,733 |
| % Growth | 6.2% | 3.1% | 0.3% | – |
| Gross Profit | $12,907 | $12,270 | $12,208 | $12,102 |
| % Margin | 66.3% | 67% | 68.7% | 68.2% |
| EBITDA | -$17,243 | -$18,723 | -$13,926 | -$7,946 |
| % Margin | -88.6% | -102.2% | -78.3% | -44.8% |
| Net Income | -$20,021 | -$22,414 | -$17,385 | -$15,158 |
| % Margin | -102.9% | -122.3% | -97.8% | -85.5% |
| EPS Diluted | -0.3 | -0.33 | -0.26 | -0.23 |
| % Growth | 9.1% | -26.9% | -13% | – |
| Operating Cash Flow | -$8,793 | -$8,214 | -$10,750 | -$10,601 |
| Capital Expenditures | -$106 | -$1,976 | -$1,491 | -$1,940 |
| Free Cash Flow | -$8,899 | -$10,190 | -$12,241 | -$12,541 |